...PIK3CA) mutational status was also determined.,Seventeen patients were treated (median age, 58; range, 44-79 years). No ...
...PIK3CA, and NOTCH1) and their corresponding pathways, with a particular focus on recent findings of Notch signaling path...
...PIK3CA amplification demonstrated partial response by RECIST and GCIG-CA125 criteria, respectively.,Pictilisib was safel...
...PIK3CA somatic mutations play a crucial role in therapy response. We investigated the presence of PIK3CA mutations in CT...
...PIK3CA; P = 0.002). In non-small cell lung cancer, PD-1/PD-L1 coexpression was identified in 8 cases (19%), which lacked...
...PIK3CA, STK11 and KIT) were exclusively altered in the tumor group. TP53 alterations were present in all the tumors but ...
...PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha, PI(3)Kα) mutation. The patient was trea...
...PIK3CA mutations, PTEN loss, PI3K and KRAS activation are early events in endometrial carcinogenesis. Molecular changes ...
...PIK3CA, KRAS, and TP53 genes as drivers and variants of the FGFR3, PDGFRA, KIT, KDR, EGFR, RET, and ATM genes. The tumor...
...PIK3CA mutant tumors. PIK3CA mutations may represent a predictive biomarker for response to PI3K inhibitors. A large-sca...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2026.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
